291 related articles for article (PubMed ID: 19659459)
1. Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.
Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
J Neurochem; 2009 Oct; 111(1):242-9. PubMed ID: 19659459
[TBL] [Abstract][Full Text] [Related]
2. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.
Deng Y; Li B; Liu Y; Iqbal K; Grundke-Iqbal I; Gong CX
Am J Pathol; 2009 Nov; 175(5):2089-98. PubMed ID: 19815707
[TBL] [Abstract][Full Text] [Related]
4. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.
Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
[TBL] [Abstract][Full Text] [Related]
6. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.
Liu Y; Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
FEBS Lett; 2008 Jan; 582(2):359-64. PubMed ID: 18174027
[TBL] [Abstract][Full Text] [Related]
7. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting.
Li X; Lu F; Wang JZ; Gong CX
Eur J Neurosci; 2006 Apr; 23(8):2078-86. PubMed ID: 16630055
[TBL] [Abstract][Full Text] [Related]
8. Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
Szablewski L
J Alzheimers Dis; 2017; 55(4):1307-1320. PubMed ID: 27858715
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
Gong CX; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Park J; Lai MKP; Arumugam TV; Jo DG
Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
[TBL] [Abstract][Full Text] [Related]
12. Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer's Disease Brain.
Gu J; Jin N; Ma D; Chu D; Iqbal K; Gong CX; Liu F
J Alzheimers Dis; 2018; 62(4):1737-1746. PubMed ID: 29614685
[TBL] [Abstract][Full Text] [Related]
13. Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.
Huang R; Tian S; Zhang H; Zhu W; Wang S
Brain Res Bull; 2020 Mar; 156():76-85. PubMed ID: 31931119
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 regulates O-GlcNAcylation of tau through OGT.
Lu S; Yin X; Wang J; Gu Q; Huang Q; Jin N; Chu D; Xu Z; Liu F; Qian W
Aging (Albany NY); 2020 Apr; 12(8):7042-7055. PubMed ID: 32310828
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus and biomarkers of neurodegeneration.
Moran C; Beare R; Phan TG; Bruce DG; Callisaya ML; Srikanth V;
Neurology; 2015 Sep; 85(13):1123-30. PubMed ID: 26333802
[TBL] [Abstract][Full Text] [Related]
16. Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease.
Gratuze M; El Khoury NB; Turgeon A; Julien C; Marcouiller F; Morin F; Whittington RA; Marette A; Calon F; Planel E
Neurobiol Dis; 2017 Feb; 98():1-8. PubMed ID: 27793638
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
[TBL] [Abstract][Full Text] [Related]
18. mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease.
Ma YQ; Wu DK; Liu JK
Mol Med Rep; 2013 Feb; 7(2):623-7. PubMed ID: 23165862
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62.
Jung HJ; Kim YJ; Eggert S; Chung KC; Choi KS; Park SA
Exp Neurol; 2013 Oct; 248():441-50. PubMed ID: 23906983
[TBL] [Abstract][Full Text] [Related]
20. Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice.
Pan D; Gu JH; Zhang J; Hu Y; Liu F; Iqbal K; Cekic N; Vocadlo DJ; Dai CL; Gong CX
J Alzheimers Dis; 2021; 81(1):273-286. PubMed ID: 33814439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
